← Open Payments lookup

COURTNEY D'ANNUNZIO: Open Payments

NPI 1871221028 · COLUMBUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$545 in 25 payments from 13 companies in 2025. Trend: 2023 $207 · 2024 $268 · 2025 $545

Food & beverage: $545
CompanyPaymentsAmount
Novo Nordisk Inc9$255
Astellas Pharma US Inc3$59
Otsuka America Pharmaceutical, Inc.2$44
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
Vanda Pharmaceuticals Inc.1$19
AstraZeneca Pharmaceuticals LP1$18
ABBVIE INC.1$18
Lilly USA, LLC1$18
Axsome Therapeutics, Inc.1$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$16

Products named: Ozempic, Veozah, Wegovy, REXULTI, CAPLYTA, FANAPT, AIRSUPRA, QULIPTA.

Industry payments across NJ — which companies pay providers there.